Norovirus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population
Condition:   NorovirusInterventions:   Biological: Norovirus GI.1/GII.4 Bivalent VLP Vaccine;   Drug: 0.9% sodium chloride (saline)Sponsor:   TakedaNot yet recruiting - verified January 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2016 Category: Research Source Type: clinical trials

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population
Condition:   NorovirusInterventions:   Biological: Norovirus GI.1/GII.4 Bivalent VLP Vaccine;   Drug: 0.9% sodium chloride (saline);   Biological: Norovirus GI.1/GII.4 Bivalent VLP VaccineSponsor:   TakedaNot yet recruiting - verified January 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2016 Category: Research Source Type: clinical trials

Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition:   Gastroenteritis NorovirusInterventions:   Biological: Snow Mountain stool filtrate;   Other: PlaceboSponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2015 Category: Research Source Type: clinical trials